ERBB2 and triple-negative breast carcinoma: Higher T and N stages, ER and PR negativity, HER2 positivity, triple-negative breast cancer (TNBC), mastectomy, high SUVRmean, and high SUVRmax were significantly observed in the recurrence group (Table 1).